They mostly refer to treatment algorithms, where certain types of tumours, such as breast adenocarcinoma, are graded for biological aggressiveness, based on a tissue sample taken either through needle biopsy or
where certain types of tumours, such as breast adenocarcinoma, are graded for biological aggressiveness, based on a tissue sample taken either through needle biopsy or via full scale tumour excision during the surgical intervention